Back

Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study)

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Advances in Chronic Thromboembolic Pulmonary Hypertension Pulmonary Embolism (PE) ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Erik Klok

Leiden University Medical Center, Leiden (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects
Mrs F. Petit Dop (Suresnes, FR)
Abstract Slides Video
Presentation thumbnail
De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty
Doctor M. Kimura (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in Chronic Thromboembolic Pulmonary Hypertension

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiopulmonary exercise testing and echocardiography in the follow-up after acute pulmonary embolism
thumbnail
Congress Presentation
Echocardiography in pulmonary embolism and chronic thromboembolic pulmonary hypertension
thumbnail
Congress Presentation
Comprehensive echocardiographic evaluation in CTEPH: the impact of TAPSE/sPAP and RVOT acceleration time on the diagnostic performance of peak tricuspid regurgitation velocity.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources